Zucara Therapeutics

Zucara Therapeutics is a diabetes life sciences company developing ZT-01, a first-in-class, once-daily therapeutic designed to prevent hypoglycemia in people with type 1 and insulin-dependent type 2 diabetes. ZT-01 works by inhibiting somatostatin, restoring glucagon secretion to prevent low blood glucose levels, improving patient health and quality of life. The company aims to revolutionize diabetes management.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $20M

Date: 12-Nov-2024

Investors: Sanofi, Perceptive Advisors' PXV Fund I

Markets: Life Sciences, Diabetes Therapeutics, Drug Discovery, Biotechnology

HQ: Toronto, Ontario, Canada

Founded: 2015

Website: https://www.zucara.ca/

LinkedIn: https://ca.linkedin.com/company/zucara-therapeutics-inc-

Twitter: https://twitter.com/zucara_ca

Instagram: